Table 3.
Reaction types and incidence of antibodies in female and male patients
| Non-severe | Severe | |||||||
|---|---|---|---|---|---|---|---|---|
| Gender | Allergy | Anaphylactoid | Febrile | Anaphylaxis | Sepsis-like | TRALI | Dyspnoea unclassified | Total |
| Female | 30·8% (8/26) | 66·7% (14/21) | 57·1% (8/14) | 29·4% (5/17) | 100% (2/2) | 100% (1/1) | 18·2% (2/11) | 43·5% (40/92) |
| Male | 19·0% (8/42) | 20·7% (6/29) | 25·9% (7/27) | 40% (6/15) | 0% (0/4) | 25% (1/4) | 30% (3/10) | 23·7% (31/131) |
| Total | 23·5% (16/68) | 40% (20/50) | 36·6% (15/41) | 43·8% (14/32) | 33·3% (2/6) | 40% (2/5) | 23·8% (5/21) | 31·8% (71/223) |